Skip to content

Selenium in epilepsy.

Effectiveness of selenium in epileptic patient’s cognitive function compared with control group

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20101209005352N3
Enrollment
70
Registered
2018-10-29
Start date
2018-08-06
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy. Epilepsy and recurrent seizures

Interventions

Intervention 1: Intervention group: epileptic patients,tab selenium 200mcg ,one tabletin at breakfast for 4months ,21centry(purapakhsh)company included purified selenium
as an antioxidant. Intervention 2: Control group: epileptic patients,tab selenium placebo 200mcg,one tab at breakfast ,for 4months,purapakhsh company.

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Adult pateints between 20_60 year’s old suffering from idiopathic generelized epilepsy. Satisfaction for participation in the study. Patients who passed at least one year from onset of the epilepsy. Patients who haven't been changed their antiepileptic drugs from one month befot to the end of intervention.

Exclusion criteria

Exclusion criteria: Patients who had seizure during one week ago. Moca score higher than 29. Pateints who suffer from major psychiatric disorders such as mood disorder, psychosis, mental retardation &...

Design outcomes

Primary

MeasureTime frame
The epileptic patient’s cognitive status based on moca test. Timepoint: Moca test at the start of study,2month &4month later. Method of measurement: Moca test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi maghbooli

Zanjan University of Medical Sciences

M.maghbooli@zums.ac.ir+98 24 3377 0801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026